PRE 14A

PRELIMINARY PROXY STATEMENT

Company: GYRE THERAPEUTICS, INC.
Filed: December 30, 2016
Period of Report: December 30, 2016
Accession Number: 0001193125-16-807885

View Document ↗ View on SEC.gov ↗